NBRV - Nabriva Therapeutics PLC (NBRV) CEO Theodore Schroeder on Q4 2020 Results - Earnings Call Transcript

Nabriva Therapeutics PLC (NBRV) Q4 2020 Earnings Conference Call March 11, 2021, 16:30 ET Company Participants Gary Sender - CFO Theodore Schroeder - CEO & Director Jennifer Schranz - Chief Medical Officer Conference Call Participants Ed Arce - H.C. Wainwright & Co. Presentation Operator Ladies and gentlemen, thank you for standing by, and welcome to the Nabriva Therapeutics Fourth Quarter 2020 Financial Results Call. [Operator Instructions]. I would now like to hand the conference over to your speaker today, Mr. Gary Sender, Chief Financial Officer. The floor is yours. Gary Sender Thank you, and good afternoon, everyone. Welcome to Nabriva's conference call and webcast to discuss the fourth quarter and full year 2020 earnings and business updates. Before we begin, I would like to remind everyone that this conference call and webcast will contain forward-looking statements about the company. These statements are subject to the risks and uncertainties that could

For further details see:

Nabriva Therapeutics PLC (NBRV) CEO Theodore Schroeder on Q4 2020 Results - Earnings Call Transcript